Effect of PAR2 in regulating TNF-α and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice
- 24 October 2010
- journal article
- research article
- Published by Springer Nature in Basic Research in Cardiology
- Vol. 106 (1) , 111-123
Abstract
Protease-activated receptor-2 (PAR2) is expressed in endothelial cells and mediates endothelium-dependent vasodilation. We hypothesized that PAR2 regulates tumor necrosis factor-alpha (TNF-α)-induced coronary arteriolar dysfunction in type 2 diabetic (db/db) mice. To test this, coronary arterioles from WT control, db/db, db/db mice treated with PAR2 antagonist FSLLRY–NH2 (db/db+FSLLRY–NH2) and db/db mice null for TNF (dbTNF−/dbTNF−) were isolated and pressurized (60 cmH2O) without flow. Although vasodilation to the endothelium-independent vasodilator sodium nitroprusside (SNP) was not different among WT, db/db, db/db+FSLLRY–NH2 and dbTNF−/dbTNF−, endothelium-dependent acetylcholine (ACh)- and flow-mediated vasodilation were impaired in db/db mice but were enhanced in dbTNF−/dbTNF− mice and db/db mice treated with PAR2 antagonist. NOS inhibitor N G-nitro-l-arginine-methyl ester (l-NAME) significantly reduced ACh-induced dilation in WT, dbTNF−/dbTNF− and db/db+FSLLRY–NH2, but did not alter the vasodilation in db/db mice. In contrast, cyclooxygenase (COX) inhibitor indomethacin (Indo) did not alter ACh-induced vasodilation in these four groups of mice. PAR2-activating peptide (PAR2-AP, 2-Furoyl-LIGRLO-am)-induced dilation was higher in db/db mice than that in WT, dbTNF−/dbTNF− and db/db mice treated with PAR2 antagonist. These effects were abolished by denudation, or in the presence of l-NAME or Indo. Protein expressions of TNF-α, PAR2, gp91phox and p47phox in the heart and isolated coronary arterioles were higher in db/db mice compared to WT mice. Administration of PAR2 antagonist to db/db mice reduced protein expression of TNF-α, gp91phox and PAR2. Protein expression of gp91phox and p47phox was lower in dbTNF−/dbTNF− compared to db/db mice. These results indicate that PAR2 plays a pivotal role in endothelial dysfunction in type 2 diabetes by up-regulating the expression/production of TNF-α and activating NAD(P)H oxidase subunit p47phox.Keywords
This publication has 47 references indexed in Scilit:
- Direct relationship between levels of TNF-α expression and endothelial dysfunction in reperfusion injuryBasic Research in Cardiology, 2010
- Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptorsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Resveratrol Improves Endothelial FunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Feed-forward signaling of TNF-α and NF-κB via IKK-β pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Role of EDHF in type 2 diabetes-induced endothelial dysfunctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- AGE/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- The role of inflammatory cytokines in endothelial dysfunctionBasic Research in Cardiology, 2008
- The therapeutic potential of proteinase-activated receptors in arthritisCurrent Opinion in Pharmacology, 2007
- Cytokine upregulation of proteinase‐activated‐receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinaseβin human endothelial cellsBritish Journal of Pharmacology, 2007
- NADPH Oxidase-Derived Overproduction of Reactive Oxygen Species Impairs Postischemic Neovascularization in Mice with Type 1 DiabetesThe American Journal of Pathology, 2006